Long-acting Injectable Cabotegravir/Rilpivirine Effective in a Small Patient Cohort With Virologic Failure on Oral Antiretroviral Therapy.

Autor:	Brock, James B, Herrington, Peyton, Hickman, Melissa, Hickman, Aubri
Předmět:	INJECTIONS VIRAL load CHRONIC diseases ANTIRETROVIRAL agents RILPIVIRINE VIREMIA
Zdroj:	Clinical Infectious Diseases; 1/15/2024, Vol. 78 Issue 1, p122-124, 3p
Abstrakt:	We report 12 patients with persistent viremia on oral antiretroviral therapy who were initiated on injectable cabotegravir/rilpivirine (iCAB/RPV) without oral lead-in. All patients achieved viral suppression without any virologic rebound. iCAB/RPV may be considered as an option for patients unable to maintain suppression on oral antiretroviral therapy. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu